TLR8−/− deficient mice were hypersensitive to TLR7/8 agonist treatment (R848), showing several indicators of inflammation, such as splenomegaly, increased serum levels of autoantibodies against dsDNA or ribonucleoprotein, and GN [46]. This evidence concerns the gene TLR8 and ganglioneuroma.